Production of recombinant protein therapeutics in cultivated mammalian cells
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Cultivated mammalian cells have become the dominant system for the production of recombinant proteins for clinical applications because of their capacity for proper protein folding, assembly and post-translational modification. Thus, the quality and efficacy of a protein can be superior when expressed in mammalian cells versus other hosts such as bacteria, plants and yeast. Recently, the productivity of mammalian cells cultivated in bioreactors has reached the gram per liter range in a number of cases, a more than 100-fold yield improvement over titers seen for similar processes in the mid-1980s. This increase in volumetric productivity has resulted mainly from improvements in media composition and process control. Opportunities still exist for improving mammalian cell systems through further advancements in production systems as well as through vector and host cell engineering.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Advances in cell engineering, process control, and media composition are credited with improving the volumetric yield of cell culture bioprocesses, making biopharmaceutical manufacturing more cost-effective and practical [8].”
From The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing (2022) · cites this paper as [8]
In the citing paper
“Chinese hamster ovary (CHO) cells are one of the main cell lines used in the production of recombinant therapeutics (Wurm, 2004; see Grillberger et al., 2009 for examples of proteins produced in CHO cells).”
From Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing (2010) · cites this paper as Wurm, 2004
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451 · cited 1×
“In 1973, Graham and van der Eb showed that exposing cells to nanoparticles of DNA and calcium phosphate makes possible DNA transfer into cultivated mammalian cell”
BackgroundEpigenetic Codes for Heterochromatin Formation and Silencing
Richards, E. J., & Elgin, S. C. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00644-x · Cited by 871
Umaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764
How introns influence and enhance eukaryotic gene expression
Le Hir, H., Nott, A., & Moore, M. J. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00052-5 · Cited by 734
Bebbington, C. R., Renner, G., Thomson, S., King, D., Abrams, D., & Yarranton, G. T. (1992) · Nature Biotechnology · doi:10.1038/nbt0292-169 · Cited by 462 · cited 1×
“At a concentration of 10–100 μM MSX, resistant clones can be identified in selected NS0 cell populations that have amplified the transgene complex containing the GS gene and the desired gene(s) of interes”
BackgroundGenetic and physical linkage of exogenous sequences in transformed cells
Perucho, M., Hanahan, D., & Wigler, M. (1980) · Cell · doi:10.1016/0092-8674(80)90178-6 · Cited by 455 · cited 1×
“Nuclear ligases assure the covalent joining of individual plasmid DNA molecule”
BackgroundExpression of recombinant plasmids in mammalian cells Is enhanced by sodium butyrate
Gorman, C. M., Howard, B. H., & Reeves, R. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.21.7631 · Cited by 367 · cited 1×
“Another way to inhibit silencing is to block deacetylation of histones using butyrat”
BackgroundSilencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9
Mutskov, V., & Felsenfeld, G. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600013 · Cited by 296
Kim, S. J., Kim, N. S., Ryu, C. J., Hong, H. J., & Lee, G. M. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19980405)58:1<73::aid-bit8>3.0.co;2-r · Cited by 220 · cited 1×
“Thus, it might be advantageous to omit selective drugs once promising clonal cell lines have been identifie”
BackgroundLarge-scale transient expression in mammalian cells for recombinant protein production
Wurm, F., & Bernard, A. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)80027-5 · Cited by 203
Self-citationHigh-level expression of recombinant IgG in the human cell line per.c6
Jones, D., Kroos, N., Anema, R., Van Montfort, B., Vooys, A., Kraats, S. V. D., Helm, E. V. D., Smits, S., Schouten, J., Brouwer, K., et al. (2003) · Biotechnology Progress · doi:10.1021/bp025574h · Cited by 158 · cited 1×
“The protein expression levels of different cell clones, including those derived from gene amplification, cover a wide range that may exceed two orders of magnitud”
BackgroundChromosomal Evolution in Cell Populations
Hsü, T. C. (1962) · International review of cytology · doi:10.1016/s0074-7696(08)60539-2 · Cited by 155
Jesus, M. J. D., Girard, P., Bourgeois, M., Baumgartner, G., Jacko, B., Amstutz, H., & Wurm, F. M. (2003) · Biochemical Engineering Journal · doi:10.1016/s1369-703x(03)00180-3 · Cited by 154
Self-citationInducible overproduction of the mouse c-myc protein in mammalian cells.
Wurm, F. M., Gwinn, K. A., & Kingston, R. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.15.5414 · Cited by 152 · cited 1×
“Upon MTX treatment, ramped upwards in concentration, the surviving cells frequently contain several hundred to a few thousand copie”
BackgroundSelf-citationAntoniou, M. N., Harland, L., Mustoe, T., Williams, S., Holdstock, J., Yagüe, E., Mulcahy, T., Griffiths, M. N. D., Edwards, S., Ioannou, P. A., et al. (2003) · Genomics · doi:10.1016/s0888-7543(03)00107-1 · Cited by 146
Zahn-Zabal, M., Kobr, M., Girod, P.-A., Imhof, M., Chatellard, P., de Jesus, M., Wurm, F., & Mermod, N. (2001) · Journal of Biotechnology · doi:10.1016/s0168-1656(00)00423-5 · Cited by 144 · cited 1×
“Flanking transgenes with these elements reduces the effects of heterochromatin and allows stable expression of the transgen”
BackgroundSelf-citationGas-inducible transgene expression in mammalian cells and mice
Weber, W., Rimann, M., Spielmann, M., Keller, B., Baba, M. D., Aubel, D., Weber, C. C., & Fussenegger, M. (2004) · Nature Biotechnology · doi:10.1038/nbt1021 · Cited by 136
Simpson, N. H., Singh, R. P., Perani, A., Goldenzon, C., & Al-Rubeai, M. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19980705)59:1<90::aid-bit12>3.0.co;2-6 · Cited by 132
Adaptation of Mammalian Cells to Growth in Serum-Free Media
Sinacore, M. S., Drapeau, D., & Adamson, S. R. (2000) · Molecular Biotechnology · doi:10.1385/mb:15:3:249 · Cited by 130 · cited 1×
“However, it still requires effort to screen several media formulations that support the transitio”
BackgroundAdvances in animal cell recombinant protein production: GS-NS0 expression system
Barnes, L. M., Bentley, C. M., & Dickson, A. J. (2000) · Cytotechnology · doi:10.1023/a:1008170710003 · Cited by 129
Kwaks, T. H. J., Barnett, P., Hemrika, W., Siersma, T., Sewalt, R. G. A. B., Satijn, D. P. E., Brons, J. F., van Blokland, R., Kwakman, P., Kruckeberg, A. L., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt814 · Cited by 126
Gene targeting in normal and amplified cell lines
Zheng, H., & Wilson, J. H. (1990) · Nature · doi:10.1038/344170a0 · Cited by 121 · cited 1×
“However, homologous recombination between transfected plasmid DNA and the genome rarely occur”
BackgroundComponents of Vectors for Gene Transfer and Expression in Mammalian Cells
Makrides, S. C. (1999) · Protein Expression and Purification · doi:10.1006/prep.1999.1137 · Cited by 116 · cited 1×
“For example, a mammalian gene that uses rare tRNA codons, and thus may not be expressed at a high level, can be converted to a high-expressing gene by changing the tRNA codons to more abundant one”
BackgroundMazur, X., Fussenegger, M., Renner, W. A., & Bailey, J. E. (1998) · Biotechnology Progress · doi:10.1021/bp980062h · Cited by 115
Animal cell technology : products of today, prospects for tomorrow
Spier, R. E., Griffiths, J. B., & Berthold, W. (1994) · Cited by 108
Effects of methotrexate on transfected DNA stability in mammalian cells.
Pallavicini, M. G., DeTeresa, P. S., Rosette, C., Gray, J. W., & Wurm, F. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.1.401 · Cited by 101
Self-citationBarnes, L. M., Bentley, C. M., & Dickson, A. J. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10893 · Cited by 99
Fernández, L. A., Winkler, M., & Grosschedl, R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.196-208.2001 · Cited by 97
Gopalkrishnan, R. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.24.4775 · Cited by 87 · cited 1×
“DNA delivery and integration Expression vectors for recombinant cell line generation generally use a strong viral or cellular promoter/enhancer to drive the expression of the recombinant gen”
BackgroundCharacterization of the stability of recombinant protein production in the GS‐NS0 expression system
Barnes, L. M., Bentley, C. M., & Dickson, A. J. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1059 · Cited by 86
Recombinant Human FSH Product Development Group (1998) · Human Reproduction Update · doi:10.1093/humupd/4.6.862 · Cited by 83
Isolation of overproducing recombinant mammalian cell lines by a fast and simple selection procedure
Wirth, M., Bode, J., Zettlmeißl, G., & Häuser, H. (1988) · Gene · doi:10.1016/0378-1119(88)90506-9 · Cited by 74
RINGOLD, G. M., Dieckmann, B. S., & Lee, F. (1981) · PubMed · Cited by 74
Kinetics of recombinant immunoglobulin production by mammalian cells in continuous culture
Robinson, D. K., & Memmert, K. (1991) · Biotechnology and Bioengineering · doi:10.1002/bit.260380903 · Cited by 62 · cited 1×
“For example, in 1991 specific productivities for the synthesis of a recombinant antibody in a myeloma cell line ranged from 20 pg/cell/day to 80 pg/cell/da”
BackgroundHomologous plasmid recombination is elevated in immortally transformed cells.
Finn, G. K., Kurz, B. W., Cheng, R. Z., & Shmookler Reis, R. J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.4009 · Cited by 50
Theoretical analysis of cell separation based on cell surface marker density
Chalmers, J. J., Zborowski, M., Moore, L. R., Mandal, S., Fang, B., & Sun, L. L. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19980705)59:1<128::aid-bit17>3.0.co;2-e · Cited by 45
Amplification and expression of recombinant genes in serum‐independent Chinese hamster ovary cells
(1995) · FEBS Letters · doi:10.1016/0014-5793(95)01328-8 · Cited by 41 · cited 1×
“With the DHFR system, expression of a recombinant protein can be augmented by exposing cells to methotrexate (MTX), a drug that blocks the activity of DHF”
BackgroundA Protein Phosphatase Is Involved in the Inhibition of Histone Deacetylation by Sodium Butyrate
Cuisset, L., Tichonicky, L., & Delpech, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8698 · Cited by 40
Gene transfer and expression in mammalian cells
Makrides, S. C. (2003) · Cited by 39
PRODUCTION OF RECOMBINANT FACTOR VIII FROM PERFUSION CULTURES: I. LARGE-SCALE FERMENTATION
Bödeker, B. G. D., Newcomb, R., Yuan, P., Braufman, A., & Kelsey, W. (1994) · Elsevier eBooks · doi:10.1016/b978-0-7506-1845-8.50133-2 · Cited by 34
Balland, A., Faure, T., Carvallo, D., Cordier, P., ULRICH, P., Fournet, B., de la Salle, H., & Lecocq, J. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb13926.x · Cited by 34
Use of scaffold/matrix-attachment regions for protein production
Girod, P., & Mermod, N. (2003) · New comprehensive biochemistry · doi:10.1016/s0167-7306(03)38022-6 · Cited by 27 · cited 1×
“Protective cis -regulatory elements include insulators, boundary elements, scaffold/matrix attachment region”
BackgroundThe LoxP/CRE System and Genome Modification
Wilson, T. J., & Kola, I. (2003) · Humana Press eBooks · doi:10.1385/1-59259-220-1:83 · Cited by 25
Integration and stability of CHO amplicons containing plasmid sequences.
Wurm, F. M., Pallavicini, M. G., & Arathoon, R. (1992) · PubMed · Cited by 23
Self-citationChapter 12 Laboratory Scaleup of Cell Cultures (0.5-50 Liters)
Mather, J. P. (1998) · Methods in cell biology · doi:10.1016/s0091-679x(08)61581-2 · Cited by 17
Architecture and utilization of highly expressed genomic sites
Bode, J., Goetze, S., Ernst, E., Hüsemann, Y., Baer, A. S., Seibler, J., & Mielke, C. (2003) · New comprehensive biochemistry · doi:10.1016/s0167-7306(03)38032-9 · Cited by 13 · cited 1×
“These enzymes catalyze the exchange at high frequency if the donor and recipient DNAs are bordered by specific attachment region”
BackgroundThe evolution of processes for the commerical exploitation of anchorage-dependent animal cells
Spier, R. E., & Kadouri, A. (1997) · Enzyme and Microbial Technology · doi:10.1016/s0141-0229(96)00213-x · Cited by 13
Cell Engineering Blocks Cell Stress and Improves Biotherapeutic Production
Arden, N., Betenbaugh, M. J., & Nivitchanyong, T. (2004) · BioProcessing Journal · doi:10.12665/j32.betenbaugh · Cited by 11
Metabolic engineering of mammalian cells for higher protein yield
Kaufmann, H., & Fussenegger, M. (2003) · New comprehensive biochemistry · doi:10.1016/s0167-7306(03)38027-5 · Cited by 10 · cited 1×
“The growth and productivity of cells can be further improved through host cell engineering, in particular by controlling growth and productivity with regulated promoter”
BackgroundMethods for DNA introduction into mammalian cells
Norton, P. A., & Pachuk, C. J. (2003) · New comprehensive biochemistry · doi:10.1016/s0167-7306(03)38016-0 · Cited by 6 · cited 1×
“Calcium phosphate transfection, electroporation, lipofection and biolistic- and polymer-mediated gene transfer are routinely used and are all reasonably efficient and reliabl”
MethodHost Cell Derived Retroviral Sequences Enhance Transfection and Expression Efficiency in CHO Cells
Wurm, F. M., Johnson, A. C., Lie, Y., Etcheverry, T., & Anderson, K. (1992) · Elsevier eBooks · doi:10.1016/b978-0-7506-0421-5.50017-9 · Cited by 6
Self-citationUse of the abiotic proton balance for describing the pH-auxostat
Siano, S. A. (1999) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19990920)64:6<741::aid-bit14>3.0.co;2-x
Research works printed but not linked: 1
- Gorman, C.M., Howard, B.H. & Reeves, R. Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. Nucleic Acids Res. 11, 7631–7648 (1983). · DOI · Paper page
Cited by
The therapeutic monoclonal antibody market
Ecker, D. M., Jones, S. D., & Levine, H. L. (2015) · mAbs · doi:10.4161/19420862.2015.989042 · Cited by 1,286
Downstream processing of monoclonal antibodies—Application of platform approaches
Shukla, A. A., Hubbard, B., Tressel, T., Guhan, S., & Low, D. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.09.026 · Cited by 876
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
Xu, X., Nagarajan, H., Lewis, N. E., Pan, S., Cai, Z., Liu, X., Chen, W., Xie, M., Wang, W., Hammond, S., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1932 · Cited by 785
“This is consistent with the observation that CHO cells do not normally show ST6Gal activity19, whereas terminal α(2,3)-linked sialic acid residues are abundant.”
InfluentialIntracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts
Stewart, M. P., Langer, R., & Jensen, K. F. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00678 · Cited by 747
Cell culture processes for monoclonal antibody production
Li, F., Vijayasankaran, N., Shen, A. (., Kiss, R., & Amanullah, A. (2010) · mAbs · doi:10.4161/mabs.2.5.12720 · Cited by 739
Metadata
- Authors
- Wurm, F. M.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- Corresponding author
- Wurm, Florian M
- ORCID
- Wurm, Florian M
- Venue
- Nature Biotechnology
- Published
- 2004-11
- Volume
- 22
- Issue
- 11
- Pages
- 1393-1398
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2118540273
- Cited by
- 2,032
- References
- 52
- Citations by year
- 2026: 52 · 2025: 51 · 2024: 66 · 2023: 66 · 2022: 64 · 2021: 77 · 2020: 89 · 2019: 114 · 2018: 162 · 2017: 118 · 2016: 95 · 2015: 135 · 2014: 108 · 2013: 145 · 2012: 111
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
- Keywords
- recombinant therapeutic proteins, mammalian cell culture, bioreactors, protein folding, post-translational modification, volumetric productivity, culture medium optimization, process control, vector engineering, host cell engineering
- MeSH terms
- Animals, Cells, Cultured, Humans, Mammals, Recombinant Proteins, Transfection, Protein Engineering, Cell Culture Techniques, Bioreactors, Genetic Enhancement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.